文献速递流行病学与生物统计临床试验与 GCP

最小充分平衡与最小化法在序贯临床试验设计中的统计特性

Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials.
PubMed 文献 · Stat Med · 2020-05-04

本研究比较最小充分平衡(MSB)与最小化法在序贯随机对照试验中平衡基线协变量的效果及分配随机性。MSB在平衡效果和分配随机性上均等于或优于最小化法,且两种方法在二分类结局分析中均保持I类错误率。

要点

  • MSB在平衡大量协变量时效果等于或优于最小化法。
  • MSB保持较高的分配随机性,减少最小化法的争议。
  • 两种方法在二分类结局分析中均保持I类错误率。

核心结论

  • MSB在平衡协变量和分配随机性方面等于或优于最小化法。
  • 两种平衡方法在二分类结局分析中均保持I类错误率。

研究设计与样本

  • 比较两种治疗分配方法在平衡协变量效果和分配随机性方面的统计特性。
  • 针对等比例分配的临床试验,使用二分类结局进行分析。

主要发现

  • MSB在平衡大量协变量时能防止严重失衡,同时保持高分配随机性。
  • MSB在平衡效果和分配随机性上等于或优于最小化法。
  • 两种方法在二分类结局分析中均保持I类错误率。

临床怎么用

  • 在序贯随机对照试验中,当需要平衡大量基线协变量时,可考虑使用MSB方法。
  • MSB可作为一种替代最小化法的方法,兼顾平衡效果和分配随机性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

When the number of baseline covariates whose imbalance needs to be controlled in a sequential randomized controlled trial is large, minimization is the most commonly used method for randomizing treatment assignments. The lack of allocation randomness associated with the minimization method has been the source of controversy, and the need to reduce even minor imbalances inherent in the minimization method has been challenged. The minimal sufficient balance (MSB) method is an alternative to the minimization method. It prevents serious imbalance from a large number of covariates while maintaining a high level of allocation randomness. In this study, the two treatment allocation methods are compared with regards to the effectiveness of balancing covariates across treatment arms and allocation randomness in equal allocation clinical trials. The MSB method proves to be equal or superior in both respects. In addition, type I error rate is preserved in analyses for both balancing methods, when using a binary endpoint.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Lauzon SD, Ramakrishnan V, Nietert PJ, et al. Statistical properties of minimal sufficient balance and minimization as methods for controlling baseline covariate imbalance at the design stage of sequential clinical trials. Stat Med. 2020. PMID: 32363614. doi:10.1002/sim.8552

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。